Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma
Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma
复制标题
神经母细胞瘤遗传风险识别染色体获得和缺失的不同检测技术的比较
DOI:
10.1007/s00428-008-0633-6
复制
发表时间:
2008
期刊:
影响因子:
3.5
通讯作者:
R. Noguera
中科院分区:
文献类型:
--
作者:
E. Villamón;M. Piqueras;Carlos Mackintosh;Javier Alonso;E. Álava;S. Navarro;R. Noguera
Neuroblastoma (NB) is a pediatric neoplasia that shows complex combinations of acquired genetic aberrations. The specific genes and the molecular mechanisms responsible for development and progression of NB remain poorly understood. Our main objective is to compare the results obtained with different techniques for the detection of genomic data in 20 patients with NB using the information obtained to select the appropriate technique in routine analysis for the therapeutic stratification. The genetic methods used in this study are multiprobe fluorescence in situ hybridization (FISH) assay, metaphasic comparative genomic hybridization (mCGH), array comparative genomic hybridization (aCGH), and the multiplex ligation-dependent probe amplification (MLPA). Genomic copy number abnormalities were used to group the cases in four categories:MYCNamplification cases; 11q deletion tumors; cases with partial chromosome gains or losses and samples with entire chromosome alterations. The data obtained from the multigenomic techniques showed a high degree of concordance and our findings support the hypothesis that NB consists of biologically distinct subgroups that differ by genetic characteristics of prognostic relevance. FISH will be essential for the mandatory study ofMYCNstatus. The use of MLPA as routine technique is an advantage procedure for detecting the implication of the common genetic alterations in NB.